v3.26.1
Erigen Assets Acquisition and Related Transactions - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Feb. 03, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2025
Jan. 20, 2026
Asset Acquisition [Line Items]            
General and administrative expense   $ 5,425   $ 3,309    
Exercise price           $ 18.48
Severance payments     $ 3,200      
Erigen Assets            
Asset Acquisition [Line Items]            
Asset acquisition, stock issued as consideration 8,268,495          
Asset Purchase Agreement            
Asset Acquisition [Line Items]            
Asset acquisition availability remained under funding commitment   13,800        
Asset Purchase Agreement | Erigen Assets            
Asset Acquisition [Line Items]            
Asset acquisition, effective date Feb. 03, 2026          
General and administrative expense         $ 2,200  
Exercise price $ 18.48          
Fair value of warrants $ 9,000          
Percentage of beneficial ownership limitation of class of warrant exercisable only for cash 9.90%          
Asset acquisition availability remained under funding commitment   13,800        
Severance payments $ 1,500          
Royalty payments   0        
Asset Purchase Agreement | Erigen Assets | Deferred Bonus            
Asset Acquisition [Line Items]            
Aggregate success bonuses $ 800          
Asset Purchase Agreement | Erigen Assets | O 2026 Q1 Dividends            
Asset Acquisition [Line Items]            
Dividend record date Jan. 30, 2026          
Asset Purchase Agreement | Erigen Assets | In Process Research and Development            
Asset Acquisition [Line Items]            
Asset aquisition expensed   $ 22,100        
Asset Purchase Agreement | Erigen Assets | Common Stock            
Asset Acquisition [Line Items]            
Asset acquisition, stock issued as consideration 8,268,495